Decision Aid Tool for Low-Risk Thyroid Cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study tests whether a decision-making tool helps patients with low-risk thyroid cancer or suspicious thyroid nodules (small lumps) feel more confident about their treatment choices. The tool is designed to help you understand your options before meeting with a surgeon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have low-risk thyroid cancer or a thyroid nodule that might be cancer
- You speak and understand English
- You have not yet met with a surgeon to discuss this thyroid problem
- Your thyroid nodule or cancer does not have high-risk features (your imaging shows it is contained in the thyroid)
- You have never had thyroid cancer or thyroid surgery before
- You are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps patients with small, low-risk thyroid cancer choose between active surveillance and immediate surgery. It focuses on shared decision-making to match the treatment to your values and preferences.
This study tests whether it is safe to monitor small, low-risk thyroid cancers (1–4 cm) instead of removing the remaining thyroid tissue after initial surgery. It may help you avoid a second operation and lifelong medication if your cancer is truly low-risk.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
This trial studies a decision-support tool to help people make choices about care for thyroid nodules that look indeterminate to cancer on biopsy. It may help you understand options and decide next steps more confidently.
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
Hear when a new Papillary Thyroid Microcarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.